Fundamentals of Clinical Psychopharmacology
Ian M. Anderson
Fundamentals of Clinical Psychopharmacology - 4th, edition illustrated, reprint, revised - London: CRC Press, c2016 - 272 Pages
In the rapidly changing field of pharmacology, it is essential that all those involved in the prescribing or administering of medication to people with mental disorders keep up to date with the latest developments. This book is based on the highly successful course for trainee psychiatrists held twice yearly in Great Britain. Leading psychiatrists
978-1-4987-1896-7 = Common terms and phrases acid action activity Acute adverse effects agonist alcohol antagonists antidepressants antipsychotics anxiety appear associated atypical autoreceptor behavioural benzodiazepines binding bipolar block brain CAMP causes cell changes channel Chapter choline clinical clinical trials Clomipramine clozapine cognitive compounds concentration controlled D₂ decrease dementia dependence depression developed disease disorder distribution dopamine dose drug efficacy elimination enzyme evidence factors Figure formed function GABA given glutamate groups half-life important improvement increase Indications inhibition inhibitors interactions leads less levels lithium measures mechanism medication metabolised mood neuron neurotransmitter occur opioid outcome panic particular pathways patients Phase placebo plasma possible postsynaptic potential practice presynaptic properties protein Psychiatry psychopharmacology randomised receptor reduce release reported response reuptake risk role schizophrenia selective severe side effects SSRIs stimulation studies symptoms Table TCAs terminal therapeutic therapy tion treated treatment trials usually withdrawal
--Medical / Psychiatry / General--Medical / Pharmacy --Medical › Psychiatry › General
Fundamentals of Clinical Psychopharmacology - 4th, edition illustrated, reprint, revised - London: CRC Press, c2016 - 272 Pages
In the rapidly changing field of pharmacology, it is essential that all those involved in the prescribing or administering of medication to people with mental disorders keep up to date with the latest developments. This book is based on the highly successful course for trainee psychiatrists held twice yearly in Great Britain. Leading psychiatrists
978-1-4987-1896-7 = Common terms and phrases acid action activity Acute adverse effects agonist alcohol antagonists antidepressants antipsychotics anxiety appear associated atypical autoreceptor behavioural benzodiazepines binding bipolar block brain CAMP causes cell changes channel Chapter choline clinical clinical trials Clomipramine clozapine cognitive compounds concentration controlled D₂ decrease dementia dependence depression developed disease disorder distribution dopamine dose drug efficacy elimination enzyme evidence factors Figure formed function GABA given glutamate groups half-life important improvement increase Indications inhibition inhibitors interactions leads less levels lithium measures mechanism medication metabolised mood neuron neurotransmitter occur opioid outcome panic particular pathways patients Phase placebo plasma possible postsynaptic potential practice presynaptic properties protein Psychiatry psychopharmacology randomised receptor reduce release reported response reuptake risk role schizophrenia selective severe side effects SSRIs stimulation studies symptoms Table TCAs terminal therapeutic therapy tion treated treatment trials usually withdrawal
--Medical / Psychiatry / General--Medical / Pharmacy --Medical › Psychiatry › General